tooyes glp-1 Agonists: Revolutionizing the Treatment of Obesity, but Are They Enough? - Eric Velazquez, MD - Bariatric Surgeon - Longstreet Clinic Center for Weight Management Subscription Box packes:3 Orforglipron, an Oral Small-Molecule

tooyes glp-1 Agonists: Revolutionizing the Treatment of Obesity, but Are They Enough? - Eric Velazquez, MD - Bariatric Surgeon - Longstreet Clinic Center for Weight Management Subscription Box packes:3 Orforglipron, an Oral Small-Molecule

Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity November 5, 2025 DOI: 10.1056/NEJMdo008238 New for the treatment of obesity - and so many additional indications being studied - orforglipron. What have

This can affect how well your body absorbs other drugs

Subscription Box

packes:3

✅ If you're flying from a UK airport to a country outside the EU, it's also worth having a quick look at your destination's customs rules around injectable medications — some countries have specific restrictions on GLP-1s like semaglutide or tirzepatide